annual cash & cash equivalents:
$47.92M-$17.14M(-26.35%)Summary
- As of today (May 29, 2025), ADPT annual cash & cash equivalents is $47.92 million, with the most recent change of -$17.14 million (-26.35%) on December 31, 2024.
- During the last 3 years, ADPT annual cash & cash equivalents has fallen by -$91.14 million (-65.54%).
- ADPT annual cash & cash equivalents is now -65.54% below its all-time high of $139.06 million, reached on December 31, 2021.
Performance
ADPT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$50.65M+$2.73M(+5.69%)Summary
- As of today (May 29, 2025), ADPT quarterly cash & cash equivalents is $50.65 million, with the most recent change of +$2.73 million (+5.69%) on March 31, 2025.
- Over the past year, ADPT quarterly cash & cash equivalents has dropped by -$20.59 million (-28.90%).
- ADPT quarterly cash & cash equivalents is now -89.81% below its all-time high of $497.08 million, reached on September 30, 2020.
Performance
ADPT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ADPT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.4% | -28.9% |
| 3 y3 years | -65.5% | -55.9% |
| 5 y5 years | -50.4% | -76.2% |
ADPT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.5% | at low | -76.7% | +33.0% |
| 5 y | 5-year | -65.5% | at low | -89.8% | +33.0% |
| alltime | all time | -65.5% | at low | -89.8% | +33.0% |
ADPT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $50.65M(+5.7%) |
| Dec 2024 | $47.92M(-26.3%) | $47.92M(+25.8%) |
| Sep 2024 | - | $38.08M(-36.3%) |
| Jun 2024 | - | $59.82M(-16.0%) |
| Mar 2024 | - | $71.23M(+9.5%) |
| Dec 2023 | $65.06M(-27.7%) | $65.06M(-26.7%) |
| Sep 2023 | - | $88.71M(-18.8%) |
| Jun 2023 | - | $109.24M(+15.5%) |
| Mar 2023 | - | $94.61M(+5.1%) |
| Dec 2022 | $90.03M(-35.3%) | $90.03M(-58.6%) |
| Sep 2022 | - | $217.55M(+184.7%) |
| Jun 2022 | - | $76.41M(-33.4%) |
| Mar 2022 | - | $114.81M(-17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $139.06M(+12.7%) | $139.06M(+13.6%) |
| Sep 2021 | - | $122.40M(-33.5%) |
| Jun 2021 | - | $184.19M(+6.1%) |
| Mar 2021 | - | $173.62M(+40.7%) |
| Dec 2020 | $123.44M(+27.8%) | $123.44M(-75.2%) |
| Sep 2020 | - | $497.08M(+36.0%) |
| Jun 2020 | - | $365.44M(+71.8%) |
| Mar 2020 | - | $212.69M(+120.2%) |
| Dec 2019 | $96.58M(+75.5%) | $96.58M(+28.9%) |
| Sep 2019 | - | $74.94M(+54.7%) |
| Jun 2019 | - | $48.46M(-56.5%) |
| Mar 2019 | - | $111.29M(+102.2%) |
| Dec 2018 | $55.03M(-35.5%) | $55.03M |
| Dec 2017 | $85.31M | - |
FAQ
- What is Adaptive Biotechnologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual cash & cash equivalents year-on-year change?
- What is Adaptive Biotechnologies quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly cash & cash equivalents year-on-year change?
What is Adaptive Biotechnologies annual cash & cash equivalents?
The current annual cash & cash equivalents of ADPT is $47.92M
What is the all time high annual cash & cash equivalents for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual cash & cash equivalents is $139.06M
What is Adaptive Biotechnologies annual cash & cash equivalents year-on-year change?
Over the past year, ADPT annual cash & cash equivalents has changed by -$17.14M (-26.35%)
What is Adaptive Biotechnologies quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ADPT is $50.65M
What is the all time high quarterly cash & cash equivalents for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly cash & cash equivalents is $497.08M
What is Adaptive Biotechnologies quarterly cash & cash equivalents year-on-year change?
Over the past year, ADPT quarterly cash & cash equivalents has changed by -$20.59M (-28.90%)